VRAX
Virax Biolabs Group Limited
stockNASDAQ
At CloseOct 2, 2026 3:54:22 PM EDT
2.20USD-1.786%(-0.04)19,611
Pre-marketOct 2, 2026 8:10:30 AM EDT
2.20USD-1.786%(-0.04)
Loading…
Loading…
1.73M
Healthcare
Biotechnology
HQ
London, United Kingdom
Previous Close
$2.24
Beta
2.10
52-Week High
$21.75 2025-12-03
52-Week Low
$2.04 2026-09-29
SMA 50
$2.73
SMA 200
$4.67
Avg. Vol 10D
34,324
Avg. Vol 30D
41,509
Avg. Vol 90D
1.29M
Relative Vol
0.47
796,988
19.57M
2455.01%
30,516
0.16%
1.00
46%/54%
47.80%
23.52%
137.8600%
60,000
803
13,292
66,299
Jun 26, 2026 · 1-for-25 (reverse)
VRAX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.31 | 2026-09-28 | -6.02% | 1.510 |
| 1M | 2.63 | 2026-09-04 | -17.14% | -2.343 |
| 3M | 3.11 | 2026-07-06 | -30.06% | 2.331 |
| 6M | 3.82 | 2026-04-06 | -43.06% | 0.984 |
| 1Y | 15.41 | 2025-10-03 | -85.89% | 2.105 |
| 2Y | 48.50 | 2024-10-04 | -95.52% | — |
| 5Y | 4,550.00 | 2022-07-21 | -99.95% | 0.904 |
VRAX Stock Summary
Virax Biolabs Group Limited (NASDAQ:VRAX) stock price today is $2.18, and today's volume is 19,611. VRAX is down 2.902% today. The 30 day average volume is 41,509. VRAX market cap is $1.73M with 796,988 shares outstanding.